[Federal Register Volume 66, Number 128 (Tuesday, July 3, 2001)]
[Notices]
[Pages 35268-35269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16680]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 4, 2000, and published in the Federal 
Register on January 10, 2001, (66 FR 2004), Medeva Pharmaceuticals CA, 
Inc., 3501 West Garry Avenue, Santa Ana,

[[Page 35269]]

California 92704, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
methylphenidate (1724), a basic class of controlled substance listed in 
schedule II.
    The firm plans to manufacture the listed controlled substance to 
make finished dosage forms for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Medeva Pharmaceuticals CA, Inc. to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Medeva 
Pharmaceuticals CA, Inc. on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic class of controlled substance listed 
above is granted.

    Dated: June 19, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-16680 Filed 7-2-01; 8:45 am]
BILLING CODE 4410-09-M